J.‐C. Wu

1.2k citations

27 papers · 907 indexed · h-index 18

Impact in

Hepatology top 1%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
Epidemiology top 5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in ⓘ

Hepatology 17
- Hepatitis C virus research 11
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Hepatitis Viruses Studies and Epidemiology 3
- Liver Disease and Transplantation 2
Epidemiology 16
- Hepatitis B Virus Studies 13
- Liver Disease Diagnosis and Treatment 6

Co-authors: Shin‐Da Lee (9 shared papers)I‐Jane Sheen (6 shared papers)Ding‐Shinn Chen (2 shared papers)Pei‐Jer Chen (2 shared papers)Tzen‐Yuh Chiang (2 shared papers)Teh‐Ia Huo (7 shared papers)Yi‐Hsiang Huang (7 shared papers)L P Ting (1 shared paper)
Journals: Journal of Viral Hepatitis (3 papers)Alimentary Pharmacology & Therapeutics (2 papers)Annals of Oncology (2 papers)Journal of General Virology (2 papers)The Journal of Infectious Diseases (2 papers)
Partner nations: Taiwan United States China

In The Last Decade

J.‐C. Wu

25 papers receiving 888 citations

Peers

Countries citing papers authored by J.‐C. Wu

Since Specialization

Citations

This map shows the geographic impact of J.‐C. Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.‐C. Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.‐C. Wu more than expected).

Fields of papers citing papers by J.‐C. Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.‐C. Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.‐C. Wu. The network helps show where J.‐C. Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside J.‐C. Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J.‐C. Wu Line = papers co-authored together J.‐C. Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Production of hepatitis delta virus and suppression of helper hepatitis B virus in a human hepatoma cell line Journal of Virology ·J.‐C. Wu, Pei‐Jer Chen, Mei‐Ying Kuo, Shin‐Da Lee, Ding‐Shinn Chen, L P Ting	1991	125
2	Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma European Journal of Surgical Oncology ·Cheng‐Yuan Hsia, Teh‐Ia Huo, Shang‐Lun Chiang, Minyan Lu, Chang-Gang Sun, J.‐C. Wu, P.-C. Lee, C.-W. Chi, W Y Lui, Shin‐Da Lee	2006	102
3	Small-form hepatitis B surface antigen is sufficient to help in the assembly of hepatitis delta virus-like particles Journal of Virology ·Rachel Wang, Pei‐Jer Chen, J.‐C. Wu, Dr.Meena A Patel, Ding‐Shinn Chen	1991	92
4	Characterization and phylogenetic analysis of a novel hepatitis D virus strain discovered by restriction fragment length polymorphism analysis. Journal of General Virology ·J.‐C. Wu, Tzen‐Yuh Chiang, I‐Jane Sheen	1998	81
5	Genetics and human conception: DNA-based X-enriched sperm separation as an adjunct to preimplantation genetic testing for the prevention of X-linked disease Human Reproduction ·Gene Levinson, Keyvan Keyvanfar, J.‐C. Wu, Edward F. Fugger, R. Fields, G. Harton, Frances T. Palmer, Michael E. Sisson, Karin M. Starr, Lisa Dennison‐Lagos, (unknown), (unknown), (unknown), (unknown), (unknown)	1995	52
6	Updated thresholds for serum alanine aminotransferase level in a large‐scale population study composed of 34 346 subjects Alimentary Pharmacology & Therapeutics ·Wen‐Chi Wu, Chen‐Yi Wu, Yan‐Jiang Wang, Hung Hsu Hung, Hwai‐I Yang, Wei‐Yu Kao, Chien‐Wei Su, J.‐C. Wu, Wah Loong Chan, Han‐Chieh Lin, F.‐Y. Lee, Shin‐Da Lee	2012	47
7	The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: A prospective survey Digestive and Liver Disease ·Teh‐Ia Huo, H.-C. Lin, Cheng‐Yuan Hsia, Yi‐Hsiang Huang, J.‐C. Wu, J.-H. Chiang, Yi‐You Chiou, W.-Y. Lui, P.-C. Lee, S.-D. Lee	2008	45
8	Recombination of hepatitis D virus RNA sequences and its implications Molecular Biology and Evolution ·J.‐C. Wu, Tzen‐Yuh Chiang, W. K. Shiue, Sheng-Yuan Wang, I‐Jane Sheen, Yi‐Hsiang Huang, W J Syu	1999	45
9	Analysis of clinical, biochemical and viral factors associated with early relapse after lamivudine treatment for hepatitis B e antigen‐negative chronic hepatitis B patients in Taiwan Journal of Viral Hepatitis ·Yi‐Hsiang Huang, J.‐C. Wu, Ting‐Tsung Chang, I‐Jane Sheen, P.‐C. Lee, Teh‐Ia Huo, Chien‐Wei Su, Yan‐Jiang Wang, F.‐Y. Chang, Shin‐Da Lee	2003	37
10	Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial Acta Neurologica Scandinavica ·Kuan‐Lin Lai, David M. Niddam, Jong‐Ling Fuh, Shih‐Pin Chen, Y.-F. Wang, W.-T. Chen, J.‐C. Wu, Shuu‐Jiun Wang	2016	32
11	Cancer risk in patients with pyogenic liver abscess: a nationwide cohort study Alimentary Pharmacology & Therapeutics ·Wei‐Yu Kao, Caleb Hwang, Y.‐T. Chang, Chien‐Wei Su, Ming Hou, Herng‐Ching Lin, F.‐Y. Lee, Shin‐Da Lee, J.‐C. Wu	2012	28
12	Coprescription of Chinese herbal medicine and Western medication among female patients with breast cancer in Taiwan: analysis of national insurance claims Patient Preference and Adherence ·Yueh‐Ching Chou, Bih-Ru Wang, Yuh-Lih Chang, Tzeng-Ji Chen, Jen-Hwey Chiu, J.‐C. Wu, Min-Shan Wu, Chia-Lin Chou	2014	27
13	Heterosexual Transmission as the Most Common Route of Acute Hepatitis B Virus Infection Among Adults in Taiwan--The Importance of Extending Vaccination to Susceptible Adults The Journal of Infectious Diseases ·Ming‐Chih Hou, J.‐C. Wu, Benjamin Ing‐Tiau Kuo, W. Y. Sheng, T.-Z. Chen, S.-D. Lee, K.-J. Lo	1993	27
14	Localization of isoprenylated antigen of hepatitis delta virus by anti-farnesyl antibodies. Journal of General Virology ·Ho-Pi Lin, Sheng‐Chieh Hsu, J.‐C. Wu, I‐Jane Sheen, Bo‐Shiun Yan, W J Syu	1999	26
15	Sequential transarterial chemoembolization and percutaneous acetic acid injection therapy versus repeated percutaneous acetic acid injection for unresectable hepatocellular carcinoma: a prospective study Annals of Oncology ·Teh‐Ia Huo, Yi‐Hsiang Huang, J.‐C. Wu, Jen‐Huey Chiang, P.-C. Lee, F.‐Y. Chang, S.-D. Lee	2003	24
16	Association of core promoter/precore mutations and viral load in e antigen‐negative chronic hepatitis B patients Journal of Viral Hepatitis ·Yi‐Hsiang Huang, J.‐C. Wu, Ting‐Tsung Chang, I‐Jane Sheen, Teh‐Ia Huo, P.‐C. Lee, Chien‐Wei Su, Shin‐Da Lee	2006	21
17	Analysis of the DNA of Hepatitis B Virus in the Sera of Chinese Patients Infected with Hepatitis B The Journal of Infectious Diseases ·J.‐C. Wu, S.-D. Lee, Jann‐Yuan Wang, Ling‐Tan Ting, Y. T. Tsai, K.-J. Lo, Benjamin N. Chiang, Ming-hua Tong	1986	20
18	Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study Annals of Oncology ·Teh‐Ia Huo, Yi‐Hsiang Huang, J.‐C. Wu, P.-C. Lee, F.‐Y. Chang, Shin‐Da Lee	2004	19
19	Long‐term evaluation of recombinant interferon α2b in the treatment of patients with hepatitis B e antigen‐negative chronic hepatitis B in Taiwan Journal of Viral Hepatitis ·Chung‐Chih Lin, J.‐C. Wu, Ting‐Tsung Chang, Yi‐Hsiang Huang, Yan‐Jiang Wang, S H Tsay, N.‐H. Chow, F.‐Y. Chang, Shin‐Da Lee	2001	16
20	Clinical, virologic and pathologic significance of elevated serum gamma-glutamyl transpeptidase in patients with chronic hepatitis C. PubMed ·Shinn‐Jang Hwang, Jiing‐Chyuan Luo, Chung-Ru Lai, Chiu‐Wing Winnie Chu, Shyh‐Haw Tsay, Chen-Xia Lu, J.‐C. Wu, F.‐Y. Chang, S D Lee	2000	16

About J.‐C. Wu

J.‐C. Wu is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Surgery and Pathology and Forensic Medicine, having authored 27 papers that have together received 907 indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (13 papers), Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Hepatitis Viruses Studies and Epidemiology (3 papers), Viral gastroenteritis research and epidemiology (2 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (2 papers) and Liver Disease and Transplantation (2 papers). The work is most often cited by research in Hepatology (566 citations), Epidemiology (601 citations), Microbiology (6 citations), Infectious Diseases (114 citations) and Virology (24 citations). J.‐C. Wu has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Shin‐Da Lee, I‐Jane Sheen, Ding‐Shinn Chen, Pei‐Jer Chen, Tzen‐Yuh Chiang, Teh‐Ia Huo, Yi‐Hsiang Huang, L P Ting, Mei‐Ying Kuo and Rachel Wang. Their work appears in journals such as Journal of Viral Hepatitis, Alimentary Pharmacology & Therapeutics, Annals of Oncology, Journal of General Virology and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact